AKT1 and prostate carcinoma: It was found that quercetin was able to reverse drug resistance in paclitaxel-resistant prostate cancer cells in vitro by reversing the activation of the androgen receptor and PI3K/Akt signaling pathway in prostate cancer treatment [28].